The interaction of the T cell receptor (TCR) with its specific ligand, peptide-MHC, is only one component of the events required for the activation of antigen-specific T cells. The primary goals of our studies are to characterize cell surface antigens (co-receptors) and their soluble or cell associated ligands (counter-receptors) which play critical roles in cell-cell interaction and in the interaction of T cells with their environment. We have concentrated our efforts in a number of distinct areas: 1) We have previously demonstrated that the human CD59 antigen and its murine homologue, Ly-6, play important roles in the T cell activation cascade. We have engineered soluble forms of both CD59 and Ly-6 and demonstrated that these fusion proteins interact with both soluble and membrane bound IgM. These studies raise the possibility that Ly-6/CD59 may play critical roles in T-B cell interaction. 2) We have shown that the newly characterized cytokine, IL10, inhibits T cell activation by acting on macrophages and not other types of accessory (AC) cells. These studies suggest that IL10 inhibits the costimulatory function of AC by preventing the induction of a critical membrane molecule needed for macrophage-T cell interaction. Studies are in progress to identify this target molecule. 3) One model of immunologic tolerance involves the induction of peripheral T cell anergy by the injection of adult mice with Staphylococcal enterotoxin B (SEB). We have reversed the tolerant state in SEB-treated mice by a concomitant infection with the nematode, Nippostrongylus brasiliensis (Nb), which results in the generation of SEB-specific IL4 producing T cells. These results have important implications for the induction of autoimmune diseases following infectious diseases. 4) In order to extend our studies to the responses of human T lymphocytes to infectious agents, we have utilized T and B lymphocyte deficient SCID mice and reconstituted them with leukocytes from patients with the tuberculoid form of leprosy. This model is being developed to analyze the requirements for the induction of a primary immune response to Mycobacterium leprae by human cells in the SCID environment.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Intramural Research (Z01)
Project #
1Z01AI000224-11
Application #
3790690
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
11
Fiscal Year
1992
Total Cost
Indirect Cost
City
State
Country
United States
Zip Code
Zhu, Jinfang; Davidson, Todd S; Wei, Gang et al. (2009) Down-regulation of Gfi-1 expression by TGF-beta is important for differentiation of Th17 and CD103+ inducible regulatory T cells. J Exp Med 206:329-41
Huter, Eva N; Stummvoll, Georg H; DiPaolo, Richard J et al. (2009) Pre-differentiated Th1 and Th17 effector T cells in autoimmune gastritis: Ag-specific regulatory T cells are more potent suppressors than polyclonal regulatory T cells. Int Immunopharmacol 9:540-5
Huter, Eva N; Punkosdy, George A; Glass, Deborah D et al. (2008) TGF-beta-induced Foxp3+ regulatory T cells rescue scurfy mice. Eur J Immunol 38:1814-21
Shevach, Ethan M; Tran, Dat Q; Davidson, Todd S et al. (2008) The critical contribution of TGF-beta to the induction of Foxp3 expression and regulatory T cell function. Eur J Immunol 38:915-7
Stummvoll, Georg H; DiPaolo, Richard J; Huter, Eva N et al. (2008) Th1, Th2, and Th17 effector T cell-induced autoimmune gastritis differs in pathological pattern and in susceptibility to suppression by regulatory T cells. J Immunol 181:1908-16
Shevach, Ethan M (2006) From vanilla to 28 flavors: multiple varieties of T regulatory cells. Immunity 25:195-201
Mendel, Itzhak; Shevach, Ethan M (2006) Activated T cells express the OX40 ligand: requirements for induction and costimulatory function. Immunology 117:196-204
Sereti, Irini; Imamichi, Hiromi; Natarajan, Ven et al. (2005) In vivo expansion of CD4CD45RO-CD25 T cells expressing foxP3 in IL-2-treated HIV-infected patients. J Clin Invest 115:1839-47
Allen, Stacey; Read, Simon; DiPaolo, Richard et al. (2005) Promiscuous thymic expression of an autoantigen gene does not result in negative selection of pathogenic T cells. J Immunol 175:5759-64
DiPaolo, Richard J; Glass, Deborah D; Bijwaard, Karen E et al. (2005) CD4+CD25+ T cells prevent the development of organ-specific autoimmune disease by inhibiting the differentiation of autoreactive effector T cells. J Immunol 175:7135-42

Showing the most recent 10 out of 48 publications